AGN 192836 is primarily utilized in ophthalmic research and treatments, particularly focusing on conditions related to intraocular pressure and glaucoma. It functions as a prostaglandin analog, which helps in reducing intraocular pressure by increasing the outflow of aqueous humor from the eye. This mechanism makes it a valuable component in the development of eye drops and other therapeutic formulations aimed at managing glaucoma and ocular hypertension. Its application is significant in improving patient outcomes by providing an effective means to control eye pressure, thereby preventing optic nerve damage and preserving vision.